Best Technique for Intramuscular Injection of Ceftriaxone (Rocephin)
Ceftriaxone should be injected deep into the body of a large muscle (ventrogluteal or vastus lateralis preferred) with aspiration before injection to avoid intravascular administration, and should be reconstituted with 1% lidocaine to significantly reduce injection pain. 1
Reconstitution and Preparation
The FDA-approved reconstitution volumes for IM ceftriaxone are specific 1:
- 250 mg vial: Add 0.9 mL diluent (yields 250 mg/mL concentration)
- 500 mg vial: Add 1.8 mL diluent for 250 mg/mL OR 1.0 mL for 350 mg/mL
- 1 gram vial: Add 3.6 mL diluent for 250 mg/mL OR 2.1 mL for 350 mg/mL
- 2 gram vial: Add 7.2 mL diluent for 250 mg/mL OR 4.2 mL for 350 mg/mL
Shake the vial thoroughly after adding diluent to ensure complete dissolution, then withdraw the entire contents into the syringe. 1
Choice of Diluent: Lidocaine Significantly Reduces Pain
Use 1% lidocaine as the diluent instead of sterile water - this is a critical clinical decision supported by high-quality evidence:
- Lidocaine reduces injection pain significantly compared to sterile water at all time points measured (immediately post-injection, 10 minutes, 20 minutes, and 6 hours) 2
- A pharmacokinetic study confirmed that 1% lidocaine and buffered lidocaine are bioequivalent to sterile water, with no difference in drug absorption or peak creatine kinase values, but both lidocaine preparations were significantly less painful than water 3
- No difference exists between plain 1% lidocaine and buffered lidocaine in terms of pain reduction, so standard 1% lidocaine is sufficient 3
The FDA label acknowledges that "some health-care providers believe that the discomfort of the injection may be reduced by using 1% lidocaine solution as a diluent" 1, though this understates the strength of evidence supporting this practice.
Injection Technique
Site selection: Inject "well within the body of a relatively large muscle"
- Ventrogluteal or vastus lateralis sites are preferred in current practice 4
- Avoid superficial injection
Aspiration: Always aspirate before injecting to avoid unintentional intravascular administration 1
Injection depth: Ensure needle penetrates deep into muscle tissue, not subcutaneous fat
Needle size: Use appropriate gauge and length for patient's body habitus to reach muscle
Special Populations
Pediatric Patients
- Acute otitis media: Single IM dose of 50 mg/kg (max 1 gram) 1
- Other infections: 50-75 mg/kg/day (max 2 grams daily) 1
- Same injection technique applies; lidocaine use is particularly important in children given pain concerns 2
Adults
- Uncomplicated gonorrhea: Single IM dose of 250 mg 5, 6, 7, 1
- Other infections: 1-2 grams once daily (max 4 grams daily) 1
Neonates
- Critical contraindication: Never use IM ceftriaxone in neonates receiving or expected to receive calcium-containing IV solutions due to precipitation risk 1
- If IM route used in neonates (rare), same large muscle injection technique applies 8
Common Pitfalls to Avoid
Using sterile water as diluent: This causes unnecessary pain when lidocaine is readily available and equally effective 2, 3
Inadequate reconstitution: Failing to shake thoroughly can result in incomplete dissolution and inaccurate dosing 1
Superficial injection: Injecting into subcutaneous tissue rather than deep muscle increases pain and may reduce absorption 1, 4
Skipping aspiration: This risks intravascular injection, which could cause adverse reactions 1
Wrong concentration: Using incorrect diluent volumes yields wrong concentrations and potentially incomplete dosing 1